Robbie Majzner
Clinical trials sponsored by Robbie Majzner, explained in plain language.
-
Immune cells engineered to attack brain tumors in kids: new trial launches
Disease control Not yet recruitingThis early-phase study tests a personalized cell therapy called B7-H3 CAR T cells in 70 children and young adults whose brain tumors have come back or are growing despite standard treatment. The therapy uses the patient's own immune cells, modified to recognize and attack a prote…
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Could engineered immune cells tackle childhood cancers that Won't quit?
Disease control Not yet recruitingThis early-stage study tests a new treatment called B7-H3 CAR T cells in up to 40 children and young adults whose solid tumors (like neuroblastoma) have come back or stopped responding to standard care. The therapy uses the patient's own immune cells, modified in a lab to better …
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated May 12, 2026 13:41 UTC